FR2679903B1 - Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. - Google Patents
Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.Info
- Publication number
- FR2679903B1 FR2679903B1 FR9109908A FR9109908A FR2679903B1 FR 2679903 B1 FR2679903 B1 FR 2679903B1 FR 9109908 A FR9109908 A FR 9109908A FR 9109908 A FR9109908 A FR 9109908A FR 2679903 B1 FR2679903 B1 FR 2679903B1
- Authority
- FR
- France
- Prior art keywords
- alkyl
- mono
- substd
- halogen
- opt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (39)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9109908A FR2679903B1 (fr) | 1991-08-02 | 1991-08-02 | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
CA002206776A CA2206776C (en) | 1991-08-02 | 1992-07-31 | N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
RU93005168A RU2104268C1 (ru) | 1991-08-02 | 1992-07-31 | Индолиновые производные, способ их получения, промежуточные соединения, фармацевтическая композиция |
JP5503337A JP2633085B2 (ja) | 1991-08-02 | 1992-07-31 | アミド官能基を有するインドリン誘導体、それらの調製、およびそれらが内在する医薬組成物 |
ZA925781A ZA925781B (en) | 1991-08-02 | 1992-07-31 | Indoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present. |
LVP-92-87A LV10091B (en) | 1991-08-02 | 1992-07-31 | Amidoindoline derivatives, method of preparation thereof and pharmaceutical composition containing them |
CZ1993682A CZ288173B6 (en) | 1991-08-02 | 1992-07-31 | Indoline derivatives, process of their preparation, intermediates for this process and pharmaceutical preparation in which these derivatives are comprised |
NZ243795A NZ243795A (en) | 1991-08-02 | 1992-07-31 | 2-carbonylamino-1-sulphonyl indoline derivatives, preparatory processes and pharmaceutical compositions |
MX9204487A MX9204487A (es) | 1991-08-02 | 1992-07-31 | Derivados de indolina y proceso para su obtencion. |
SK426-93A SK283463B6 (sk) | 1991-08-02 | 1992-07-31 | Indolínové deriváty, spôsob ich prípravy, medziprodukty tohto spôsobu a farmaceutický prostriedok obsahujúci tieto deriváty |
UA93002340A UA27238C2 (uk) | 1991-08-02 | 1992-07-31 | Індолінові похідні, а також їх фармацевтично прийнятні солі, що є антагоністами вазопресинових v1-рецепторів, спосіб їх одержання, проміжні продукти і фармацевтична композиція |
KR1019930701034A KR100241583B1 (ko) | 1991-08-02 | 1992-07-31 | 아미드 작용기를 갖는 인돌린 유도체, 그의 제조방법 및 그를 함유하는 약학적 조성물 |
CA002093221A CA2093221C (en) | 1991-08-02 | 1992-07-31 | N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present |
AU24758/92A AU658664B2 (en) | 1991-08-02 | 1992-07-31 | Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them |
IL102703A IL102703A (en) | 1991-08-02 | 1992-07-31 | N-sulfonyl indoline derivatives carrying an amide functional group, their preparation and pharmaceutical compositions containing them |
LTIP114A LT3064B (en) | 1991-08-02 | 1992-07-31 | Indolineamide derivatives, process for the preparation thereof and pharmaceutical compositions containing the same |
IL11759292A IL117592A (en) | 1991-08-02 | 1992-07-31 | N-substituted sulfonamidobenzene compounds |
HU9300951A HUT68927A (en) | 1991-08-02 | 1992-07-31 | Process for producing indoline derivatives and pharmaceutical compositions containing them |
PH44760A PH30661A (en) | 1991-08-02 | 1992-07-31 | N-sulfonylindoline derivatives their preparation and the pharmaceutical compositions in which tey are present |
MYPI92001379A MY110517A (en) | 1991-08-02 | 1992-07-31 | Indoline derivatives carrying an amide functional group their preparation and the pharmaceutical compositions in which they are present. |
BR9205336A BR9205336A (pt) | 1991-08-02 | 1992-07-31 | Composto,processo para a preparacao do mesmo,utilizacao do composto e composicao farmaceutica |
PCT/FR1992/000758 WO1993003013A1 (fr) | 1991-08-02 | 1992-07-31 | Derives d'indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant |
DK92402213T DK0526348T3 (da) | 1991-08-02 | 1992-08-03 | Indolderivater, der bærer en amidfunktion, samt deres fremstilling og farmaceutiske sammensætninger indeholdende sådanne |
EP92402213A EP0526348B1 (fr) | 1991-08-02 | 1992-08-03 | Dérivés d'indoline portant une fonction amidique, leur préparation, les compositions pharmaceutiques en contenant |
ES92402213T ES2117038T3 (es) | 1991-08-02 | 1992-08-03 | Derivados de indolina que llevan una funcion amidica, su preparacion, las composiciones farmaceuticas que los contienen. |
SG1996002367A SG47501A1 (en) | 1991-08-02 | 1992-08-03 | N-sulfonyl indoline derivatives carrying an amide functional group their preparation and the pharmaceutical compositions in which they are present |
DE69224450T DE69224450T2 (de) | 1991-08-02 | 1992-08-03 | Indolinderivate mit einer Amidgruppe, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
US07/923,839 US5338755A (en) | 1990-07-31 | 1992-08-03 | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
AT92402213T ATE163289T1 (de) | 1991-08-02 | 1992-08-03 | Indolinderivate mit einer amidgruppe, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen |
NO931262A NO180047C (no) | 1991-08-02 | 1993-04-01 | Indolinderivater med en amidgruppe og farmasöytiske blandinger som inneholder dem |
FI931476A FI104069B1 (fi) | 1991-08-02 | 1993-04-01 | Menetelmä terapeuttisesti käyttökelpoisten 3-(fenyyli- tai sykloalkyyli)-3-hydroksi-1-fenyylisulfonyyli-2-indoliinikarboksamidijohdannaisten valmistamiseksi |
US08/240,360 US5397801A (en) | 1990-07-31 | 1994-05-10 | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
US08/348,150 US5481005A (en) | 1990-07-31 | 1994-11-28 | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
AU11541/95A AU691223B2 (en) | 1991-08-02 | 1995-02-03 | Intermediates useful in the preparation of indoline derivatives carrying an amide functional group |
US08/458,614 US5578633A (en) | 1990-07-31 | 1995-06-02 | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
HU95P/P00474P HU211884A9 (en) | 1991-08-02 | 1995-06-28 | Indoline derivatives and pharmaceutical compositions containing them |
IL11759296A IL117592A0 (en) | 1991-08-02 | 1996-03-21 | N-substituted sulfonamidobenzene compounds |
FI980175A FI107048B (fi) | 1991-08-02 | 1998-01-27 | 2-sulfonamidofenonijohdannaisia |
HK98108861A HK1008741A1 (en) | 1991-08-02 | 1998-07-03 | Indoline derivatives carrying an amide function their preparation and pharmaceutical compositions containing them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9109908A FR2679903B1 (fr) | 1991-08-02 | 1991-08-02 | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2679903A1 FR2679903A1 (fr) | 1993-02-05 |
FR2679903B1 true FR2679903B1 (fr) | 1993-12-03 |
Family
ID=9415909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9109908A Expired - Fee Related FR2679903B1 (fr) | 1990-07-31 | 1991-08-02 | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0526348B1 (sk) |
JP (1) | JP2633085B2 (sk) |
KR (1) | KR100241583B1 (sk) |
AT (1) | ATE163289T1 (sk) |
AU (2) | AU658664B2 (sk) |
BR (1) | BR9205336A (sk) |
CA (2) | CA2093221C (sk) |
CZ (1) | CZ288173B6 (sk) |
DE (1) | DE69224450T2 (sk) |
DK (1) | DK0526348T3 (sk) |
ES (1) | ES2117038T3 (sk) |
FI (2) | FI104069B1 (sk) |
FR (1) | FR2679903B1 (sk) |
HK (1) | HK1008741A1 (sk) |
HU (2) | HUT68927A (sk) |
IL (3) | IL117592A (sk) |
LT (1) | LT3064B (sk) |
LV (1) | LV10091B (sk) |
MX (1) | MX9204487A (sk) |
MY (1) | MY110517A (sk) |
NO (1) | NO180047C (sk) |
NZ (1) | NZ243795A (sk) |
PH (1) | PH30661A (sk) |
RU (1) | RU2104268C1 (sk) |
SG (1) | SG47501A1 (sk) |
SK (1) | SK283463B6 (sk) |
UA (1) | UA27238C2 (sk) |
WO (1) | WO1993003013A1 (sk) |
ZA (1) | ZA925781B (sk) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2665441B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant. |
FR2708608B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. |
FR2756736B1 (fr) * | 1996-12-05 | 1999-03-05 | Sanofi Sa | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline |
US7030114B1 (en) | 1997-07-31 | 2006-04-18 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6492421B1 (en) | 1997-07-31 | 2002-12-10 | Athena Neurosciences, Inc. | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6362341B1 (en) | 1997-07-31 | 2002-03-26 | Athena Neurosciences, Inc. | Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6489300B1 (en) | 1997-07-31 | 2002-12-03 | Eugene D. Thorsett | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
EP0994896A1 (en) * | 1997-07-31 | 2000-04-26 | Elan Pharmaceuticals, Inc. | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
CA2290749A1 (en) * | 1997-07-31 | 1999-02-11 | Elan Pharmaceuticals, Inc. | Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
US6559127B1 (en) | 1997-07-31 | 2003-05-06 | Athena Neurosciences, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6939855B2 (en) | 1997-07-31 | 2005-09-06 | Elan Pharmaceuticals, Inc. | Anti-inflammatory compositions and method |
IL133641A0 (en) * | 1997-07-31 | 2001-04-30 | Elan Pharm Inc | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
US6291453B1 (en) | 1997-07-31 | 2001-09-18 | Athena Neurosciences, Inc. | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6423688B1 (en) | 1997-07-31 | 2002-07-23 | Athena Neurosciences, Inc. | Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6583139B1 (en) | 1997-07-31 | 2003-06-24 | Eugene D. Thorsett | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
FR2775598A1 (fr) * | 1998-03-06 | 1999-09-10 | Sanofi Sa | Compositions pharmaceutiques contenant en association un antagoniste selectif des recepteurs v1a de l'arginine-vasopressine et un antagoniste selectif des recepteur v2 de l'arginine-vasopressine |
FR2778103A1 (fr) * | 1998-04-29 | 1999-11-05 | Sanofi Sa | Compositions pharmaceutiques contenant en association un antagoniste v1a de l'arginine-vasopressine et un antagoniste des recepteurs at1 de l'angiotensine ii |
FR2786486B3 (fr) * | 1998-11-16 | 2000-12-08 | Sanofi Sa | Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates |
CN1220683C (zh) | 1999-01-22 | 2005-09-28 | 依兰制药公司 | 用于治疗与vla-4有关的疾病的酰基衍生物 |
TW593284B (en) | 1999-01-22 | 2004-06-21 | Elan Pharm Inc | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
EP1150997A1 (en) * | 1999-01-25 | 2001-11-07 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
US6407066B1 (en) | 1999-01-26 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
FR2792834A1 (fr) * | 1999-04-29 | 2000-11-03 | Sanofi Sa | Utilisation du sr 49059, de ses solvats et/ou hydrates pharmaceutiquement acceptables, pour la preparation de medicaments utiles dans le traitement ou la prevention du phenomene de raynaud |
FR2805536B1 (fr) | 2000-02-25 | 2002-08-23 | Sanofi Synthelabo | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant |
FR2805992A1 (fr) * | 2000-03-08 | 2001-09-14 | Sanofi Synthelabo | Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline |
CA2423933A1 (en) | 2000-10-17 | 2002-04-25 | Applied Research Systems Ars Holding N.V. | Pharmaceutically active sulfanilide derivatives |
US7056910B2 (en) | 2000-11-28 | 2006-06-06 | Astellas Pharma Inc. | 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
JP4044740B2 (ja) * | 2001-05-31 | 2008-02-06 | 信越化学工業株式会社 | レジスト材料及びパターン形成方法 |
AU2002364291B2 (en) | 2001-12-20 | 2007-08-02 | Merck Serono Sa | Triazoles as oxytocin antagonists |
TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
US7238717B2 (en) | 2002-05-24 | 2007-07-03 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
CN1332942C (zh) * | 2002-10-11 | 2007-08-22 | 埃科特莱茵药品有限公司 | 磺酰基氨基-乙酸衍生物及其作为阿立新受体拮抗剂的应用 |
US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
US7227035B2 (en) | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
CN101077867B (zh) | 2002-11-18 | 2012-10-10 | 坎莫森特里克斯公司 | 芳基磺酰胺 |
US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
ZA200803016B (en) | 2005-09-29 | 2009-10-28 | Elan Pharmaceuticals Inc Wyeth | Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
EA015388B1 (ru) | 2005-09-29 | 2011-08-30 | Элан Фамэсьютикэлс, Инк. | ПИРИМИДИНИЛАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), ВКЛЮЧАЮЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО α4-ИНТЕГРИНАМИ |
TWI389904B (zh) | 2006-02-27 | 2013-03-21 | Elan Pharm Inc | 抑制由vla-4所調節的白血球黏附之嘧啶磺醯胺化合物 |
US8367836B2 (en) | 2009-04-27 | 2013-02-05 | Elan Pharmaceuticals, Inc. | Pyridinone antagonists of alpha-4 integrins |
TW201938171A (zh) | 2017-12-15 | 2019-10-01 | 匈牙利商羅特格登公司 | 作為血管升壓素V1a受體拮抗劑之三環化合物 |
HU231206B1 (hu) | 2017-12-15 | 2021-10-28 | Richter Gedeon Nyrt. | Triazolobenzazepinek |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3838167A (en) * | 1972-08-01 | 1974-09-24 | Lilly Co Eli | Process for preparing indoles |
US4479963A (en) * | 1981-02-17 | 1984-10-30 | Ciba-Geigy Corporation | 1-Carboxyalkanoylindoline-2-carboxylic acids |
DE3705934A1 (de) * | 1987-02-25 | 1988-09-08 | Nattermann A & Cie | Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
FR2665441B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant. |
-
1991
- 1991-08-02 FR FR9109908A patent/FR2679903B1/fr not_active Expired - Fee Related
-
1992
- 1992-07-31 NZ NZ243795A patent/NZ243795A/en unknown
- 1992-07-31 LT LTIP114A patent/LT3064B/lt not_active IP Right Cessation
- 1992-07-31 KR KR1019930701034A patent/KR100241583B1/ko not_active IP Right Cessation
- 1992-07-31 RU RU93005168A patent/RU2104268C1/ru not_active IP Right Cessation
- 1992-07-31 CZ CZ1993682A patent/CZ288173B6/cs not_active IP Right Cessation
- 1992-07-31 ZA ZA925781A patent/ZA925781B/xx unknown
- 1992-07-31 HU HU9300951A patent/HUT68927A/hu unknown
- 1992-07-31 MX MX9204487A patent/MX9204487A/es not_active IP Right Cessation
- 1992-07-31 CA CA002093221A patent/CA2093221C/en not_active Expired - Fee Related
- 1992-07-31 AU AU24758/92A patent/AU658664B2/en not_active Ceased
- 1992-07-31 LV LVP-92-87A patent/LV10091B/lv unknown
- 1992-07-31 CA CA002206776A patent/CA2206776C/en not_active Expired - Fee Related
- 1992-07-31 SK SK426-93A patent/SK283463B6/sk unknown
- 1992-07-31 MY MYPI92001379A patent/MY110517A/en unknown
- 1992-07-31 JP JP5503337A patent/JP2633085B2/ja not_active Expired - Fee Related
- 1992-07-31 PH PH44760A patent/PH30661A/en unknown
- 1992-07-31 IL IL11759292A patent/IL117592A/xx not_active IP Right Cessation
- 1992-07-31 WO PCT/FR1992/000758 patent/WO1993003013A1/fr active IP Right Grant
- 1992-07-31 BR BR9205336A patent/BR9205336A/pt not_active Application Discontinuation
- 1992-07-31 UA UA93002340A patent/UA27238C2/uk unknown
- 1992-07-31 IL IL102703A patent/IL102703A/xx not_active IP Right Cessation
- 1992-08-03 DK DK92402213T patent/DK0526348T3/da active
- 1992-08-03 DE DE69224450T patent/DE69224450T2/de not_active Expired - Fee Related
- 1992-08-03 EP EP92402213A patent/EP0526348B1/fr not_active Expired - Lifetime
- 1992-08-03 ES ES92402213T patent/ES2117038T3/es not_active Expired - Lifetime
- 1992-08-03 AT AT92402213T patent/ATE163289T1/de not_active IP Right Cessation
- 1992-08-03 SG SG1996002367A patent/SG47501A1/en unknown
-
1993
- 1993-04-01 FI FI931476A patent/FI104069B1/fi not_active IP Right Cessation
- 1993-04-01 NO NO931262A patent/NO180047C/no not_active IP Right Cessation
-
1995
- 1995-02-03 AU AU11541/95A patent/AU691223B2/en not_active Ceased
- 1995-06-28 HU HU95P/P00474P patent/HU211884A9/hu unknown
-
1996
- 1996-03-21 IL IL11759296A patent/IL117592A0/xx unknown
-
1998
- 1998-01-27 FI FI980175A patent/FI107048B/fi not_active IP Right Cessation
- 1998-07-03 HK HK98108861A patent/HK1008741A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2679903B1 (fr) | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. | |
IL97612A0 (en) | N-substituted heterocyclic derivatives,their preparation and pharmaceutical compositions containing them | |
MX2021001022A (es) | Compuestos similares a 17beta-heterociclil-digitalis para el tratamiento de la insuficiencia cardiaca. | |
GB1505848A (en) | 3,4-dicarboxycephalosporins and derivatives | |
HUP9902606A2 (hu) | Mátrix metalloproteináz inhibitorok | |
ZA200109049B (en) | New pharmaceutically active compounds. | |
FR2191887A1 (en) | 7-Substd 5-hydroxy-imidazo pyrimidines - antiinflammatories, and immuno-suppressives, from 2-aminoimidazoline and substd ethyl acetates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CA | Change of address | ||
CD | Change of name or company name | ||
TP | Transmission of property | ||
ST | Notification of lapse |